Improved antisense oligonucleotide induced exon skipping in the <i>mdx</i> mouse model of muscular dystrophy

Abstract

These results demonstrate the increasing feasibility of an AO-based therapy for treatment of DMD. By refining AO design we have been able to reduce the size and the effective dose of the AOs and have dramatically improved the efficiency of the technique.